Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Andrew Holden Added: 2 weeks ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II… View more
Author(s): Ari Kramer Added: 1 week ago
Real-world outcomes from the FLEX Vessel Prep (VP) system in arteriovenous fistulae and grafts show good safety results with no serious adverse events at 30 days and a high six-month primary patency rate.Dr Ari Kramer (Spartanburg Medical Centre, Spartanburg, US) joins us to discuss outcomes from the prospective, multi-centre, observational study using the FLEX FIRST AV registry (NCT05616104;… View more
Author(s): Nouf Alanazi , Alaide Chieffo , Added: 1 week ago
TCT Middle East 2025 — We are joined by Dr Nouf Alanazi, Dr Alaide Chieffo and Dr Nadia Sutton as they discuss key takeaways from the conference for the physiological assessment of coronary artery disease.The panel explores emerging paradigms in MINOCA and INOCA management, addressing the limitations of conventional approaches. They review current guideline recommendations for functional testing… View more
Author(s): Harriette Van Spall , Stefan James Added: 8 months ago
ESC Congress 2024 — SWEDEGRAFT does not support the routine use of no-touch vein harvest compared to the standard technique.Dr Harriette Van Spall (McMaster University, CA) sits down with principal investigator Prof Stefan James (Uppsala University, SE) to discuss results of the SWEDEGRAFT trial (NCT03501303; Uppsala University).The SWEDEGRAFT trial is a prospective, binational, multicenter, open… View more